Accessibility Menu
OrthoPediatrics logo

OrthoPediatrics(NASDAQ) KIDS

Market Cap$669.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)+38%
5 Year-60%
1 Year+34%
1 Month+33%
Premium Feature
Moneyball Superscore
60/100
$25.61
-2.36%
-0.62Today
After hours$25.67+$0.06 (+0.23%)
OrthoPediatrics last closing stock price
MetricPriceDate
Last closeUSD 25.652026-08-21
OrthoPediatrics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.43%USD 24.802026-08-14
1 month+33.18%USD 19.262026-07-22
3 month+39.63%USD 18.372026-05-22
Year to date+44.43%USD 17.762025-12-31
1 year+33.94%USD 19.152025-08-21
3 year-30.81%USD 37.072023-08-22
5 year-59.54%USD 63.402021-08-20
Since inception+37.88%USD 19.222017-10-12

OrthoPediatrics Financials at a Glance

Market Cap

$669.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$252.73M

Net Income (TTM)

-$39.73M

EPS (TTM)

-$1.68

P/E Ratio

-15.29

Dividend

$0.00

Beta (Volatility)

1.22 (Average)

Price

$25.61

Volume

364,624.79

Open

$26.23

Previous Close

$25.65

Daily Range

$25.23 - $26.23

52-Week Range

$14.42 - $26.74

Estimated Earnings Date

Oct 27, 2026

KIDS News

Foolcom-Featured.png

OrthoPediatrics (KIDS) Q2 Revenue Up 16%

Motley Fool Markets TeamAug 5, 2025
GettyImages-1204177559

3 Stocks to Buy and Hold for the Long Term

Taylor CarmichaelAug 21, 2022

KIDS: Motley Fool Moneyball Superscore

60

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About OrthoPediatrics

OrthoPediatrics Corp. makes surgical tools and braces for children. These products help doctors treat bone injuries and spine curves. Devices are designed specifically for small, growing bodies.

Tools for Growing Bones

  • Trauma and Deformity: Implants and screws to fix broken bones and limb issues; generated $95.7 million in revenue for the six months ended June 30, 2026.
  • Scoliosis: Surgical systems to treat spine curvature; accounted for $32.3 million in revenue for the six months ended June 30, 2026.
  • Sports Medicine: Devices for ligament reconstruction and joint injuries in children; contributed $1.9 million in revenue for the six months ended June 30, 2026.
  • Specialty Bracing: Non-surgical braces and clinical services provided through more than 50 orthotic and prosthetic clinics.

Building a Global Network

  • Launched a global restructuring plan in 2024 to improve efficiency and integrate new products.
  • Established a legal entity in Brazil in Nov. 2025 to sell and distribute products directly.
  • Opened new warehouses in Germany and Australia in 2024 to support international expansion.
  • Added a distribution warehouse in the Netherlands in 2025 to enhance European operations.
  • Secured a $20 million delayed draw term loan in March 2026 for flexible capital access.

What Sets the Company Apart?

The company is the only global medical device firm focused exclusively on the pediatric orthopedic market. It uses a consignment model where revenue is recognized only after a surgeon uses the device, accounting for 60% of total net sales in the first half of 2026.

Financial Performance

  • Net revenue was $129.9 million for the six months ended June 30, 2026, up 14% year over year.
  • Gross margin reached 74% for the six-month period ended June 30, 2026, up from 72% year over year.
  • Net loss was $17.9 million for the six months ended June 30, 2026.
  • Cash and short-term investments totaled $47.9 million as of June 30, 2026.
  • Market capitalization was $573 million as of the current reporting period.

Bottom Line

OrthoPediatrics has transitioned from a specialized manufacturer into a global leader in pediatric orthopedic care. Its expansion into international direct sales and clinical services supports its goal of addressing the unique needs of young patients.

AI Generated • Aug 6, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

602

CEO

David R. Bailey

Website

www.orthopediatrics.com

Headquarters

Warsaw, IN 46582, US

KIDS Financials

Key Financial Metrics (TTM)

Gross Margin

73.65%

Operating Margin

-9.01%

Net Income Margin

-15.72%

Return on Equity

-11.53%

Return on Capital

-6.49%

Return on Assets

-7.77%

Earnings Yield

-6.54%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$669.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

26.11M

Volume

364.62K

Avg. Volume

179.97K

Financials (TTM)

Gross Profit

$186.14M

Operating Income

-$22.78M

EBITDA

-$10.25M

Operating Cash Flow

$7.41M

Capital Expenditure

-$9.24M

Free Cash Flow

-$1.84M

Cash & ST Invst.

$45.88M

Total Debt

$91.59M

OrthoPediatrics Performance Analysis

OrthoPediatrics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 122,289,00024.7%
20232023-12-31USD 148,732,00021.6%
20242024-12-31USD 204,727,00037.6%
20252025-12-31USD 236,348,00015.4%
OrthoPediatrics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-300.3%
Q42025-12-310.6%
Q12026-03-31-3.6%
Q22026-06-3018.8%
OrthoPediatrics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.06N/A
20232023-12-31USD -0.93N/A
20242024-12-31USD -1.6477.2%
20252025-12-31USD -1.693.1%
OrthoPediatrics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-66.7%
Q42025-12-3114.0%
Q12026-03-31-4.7%
Q22026-06-3033.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$70.51M

+15.4%

Gross Profit

$52.37M

+19.0%

Gross Margin

74.27%

N/A

Market Cap

$669.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.11M

N/A

Employees

602

N/A

Net Income

-$7.16M

-0.7%

EBITDA

-$4.40M

-465.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$45.88M

-34.6%

Total Debt

$91.59M

-5.7%

Accounts Receivable

$60.95M

+13.3%

Inventory

$137.57M

+9.8%

Long Term Debt

$91.42M

-5.8%

Short Term Debt

$172.00K

+4.9%

Return on Assets

-7.77%

N/A

Return on Invested Capital

-4.97%

N/A

Free Cash Flow

-$3.12M

+77.6%

Operating Cash Flow

$928.00K

+108.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EHABEnhabit, Inc.
$13.80+0.07%
SRDXSurmodics, Inc.
$42.98+0.35%
EOLSEvolus, Inc.
$8.39+0.48%
TOIThe Oncology Institute, Inc.
$5.13-19.72%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.10%
IBITiShares Bitcoin Trust
$43.68+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$10.41+0.06%
MARAMara Holdings
$11.26+0.01%

Questions About KIDS

What is the current price of OrthoPediatrics?

OrthoPediatrics is trading at $25.65 per share.

What is the 52-week range for OrthoPediatrics?

Over the past 52 weeks, OrthoPediatrics has traded between $14.42 and $26.74.

How much debt does OrthoPediatrics have?

As of the most recent reporting period, OrthoPediatrics reported total debt of $106.06M.

How much cash does OrthoPediatrics have on hand?

OrthoPediatrics reported $19.06M in cash and cash equivalents in its most recent financial results.

What is OrthoPediatrics’s dividend yield?

OrthoPediatrics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services